Angiogenesis in squamous intraepithelial neoplasia of the uterine cervix in HIV-seropositive women

Objectives: This study aimed to quantify angiogenesis in squamous intraepithelial lesions of the uterine cervix in seropositive HIV patients as well as to establish a relationship between vascular density and variations in the CD4+ lymphocyte titer and the viral load of human immunodeficiency virus (HIV).

Methods: 125 patients, 55 HIV seropositive and 70 seronegative, were allocated with respect to grade of squamous intraepithelial lesion (SIL). The obtained samples were stained with an immunohistochemical marker for CD34 antigen and vessel counts were performed in ten consecutive fields at 400x magnification. The seropositive HIV patients were distributed into groups according to the CD4+ index and HIV viral load.

Results: Seropositive HIV patients presented a higher mean vascular density (MVD) than the control group, even in the absence of cervical intraepithelial lesions. High- and low-grade lesions in the presence of HIV seropositivity presented higher MVD than that found in seronegative HIV patients. There was no significant variation in the MVD and CD4+ count ratio or viral RNA-HIV load, except for high-grade (H)SIL.

Conclusions: Infection with HIV influenced angiogenesis of uterine cervix in the presence of squamous intraepithelial lesions and more significantly in HSIL.

Angiogenesis; HIV; CIN; SIL

[1] Brasil. Minist如o da Saude. Secretaria de Assistencia a Saude. Programa Nacional de DST e AIDS. Boletim Epidemiológico AIDS. Brasilia, Ministerio da Satide, 2003, 52.

[2] Brito A.M., Castilho E.A., Szwarcwald C.L.: "AIDS e infeccao pelo HIV no Brasil: uma epidemia multifacetada". Rev. Soc. Bras. Med. Trop., 2000, 34, 207.

[3] Henry M.J., Stanley M.W., Cruikshank S., Carson L.: "Association of immunodeficiency virus-induced immunosuppression with human papillomavirus infection and cervical intraepithelial neoplasia". Am. J. Obstet. Gynecol., 1989, 160, 352.

[4] Schiffer A., Friedmann W., Mielke M., Schwartlander B., Koch M.A.: "The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeciency virus is related to the degree of immunosuppression". Am. J. Obstet. Gynecol., 1991, 164, 593.

[5] Yermund S.H., Kelley K.F., Klein R.S., Feingold A.R. et al.: "High risk of papillomavirus infection and cervical squamous intraepitelial lesions among women with symptomatic human immunodeficiency virus infection". Am..T. Obstet. Gynecol., 1991, 165, 392.

[6] Chin K.M., Sidhu J.S., Janssen R.S., Weber J.T.: "Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients". Obstet. Gynecol., 1998, 92, 83.

[7] Auge A.P.F., Piato S., Frade A.B. et al.: "Frequencia de neoplasia intra-epitelial cervical em portadoras do virus da imunodeficiencia humana". Rev. Bras. Ginecol. Obstet., 2000, 22, 573.

[8] Thomas D.B., Ray R.M., Kuypers J. et al.: "Human papillomaviruses and cervical canncer in Bagkok. Ill. The role of husband and commercial sex workers". Am. J. Epidemiol., 2001, 153, 740.

[9] Melo Y.H., Araujo A.C.L., Rio S.M.P., Castro L.P.F., Azevedo A.A., Castro M.M.: "Problemas gineco16gicos mais freqiientes em mulheres soropositivas para o HIV". Rev. Bras. Ginecol. Obstet., 2003, 25, 661.

[10] Pautier P., Morice P., Crevoisier R.: "HIV and uterine cervical cancer". Bull. Cancer, 2003, 90, 399.

[11] Suarez Rincon A.E.S., Valls E.Y., Rodriguez M.R., Fuentes H.M., Rodriguez M.C., Corona J.S.: "Lesiones escamosas intraepiteliaes en pacientes VIH seropositivas. Su frecuencia y asociación confactores de riesgo para neoplasia cervical". Ginec. y Obstet. Mex, 2003, 71, 32.

[12] Palefsky J.M., Holly E.A.: "lmmunosuppression and co-infection with HIV". J. Natl. Cancer Inst. Monogr., 2003, 31, 41.

[13] Sillman F., Boyce J., Fruchter R.: "The significance of atypical vessels and neovascularization in cervical neoplasia". Am. J Obstet. Gynecol., 1981, 139, 154.

[14] Soncini E., Condemi V.: "Carcinoma cervicale intraepiteliale ed HIV: prevalenza, fattori di rischio e strategie di prevenzione". Minerva Ginecol., 2003, 55, 51.

[15] Weissenborn SJ., Funke A.M., Hellmich M. et al.: "Oncogemc human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are elevated". J. Clin. Microbial., 2003, 41, 2763.

[16] CDC - Centers for Disease Control. "1993 revised classificat10n system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults". JAMA, 1993, 269, 729.

[17] Heard I., Tassie J.M., Schmitz V., Mandelbrot L., Kazatchkine M.D., Orth G.: "Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load". Obstet. Gynecol., 2000, 96, 403.

[18] Saag M.S.: "Use of HIV viral load in clinical practice: back to the future". Ann. Intern. Med., 1997, 126, 983.

[19] Ellerbrock T.V., Chiasson M.A., Bush T.J. et al.: "Incidence of cervical squamous intraepithelial lesions in HIV-infected women" JAMA, 2000, 283, 1031.

[20] Conley L.J., Ellerbrock T.V., Bush T.J., Chiasson M.A., Sawo D., Wrigth T.C.: "HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study". Lancet, 2002, 359, 108.